Brain Metastases Clinical Trials in Miami, Florida

4 studies are recruiting for brain metastases in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

   Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

   Locations

   86 in total

   Run by

   Canadian Cancer Trials Group

   See if you can join NCT03550391 on ClinicalTrials.gov

2. 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

   This is a pilot imaging study in participants treated with stereotactic radiosurgery (SRS) to treat brain metastasis. The purpose of this study is to see whether 18F-Fluciclovine positron emission tomography (PET) can be used as a biomarker to measure response or progression of brain metastasis aft…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Miami Cancer Institute, Miami, Florida

   Run by

   Baptist Health South Florida

   See if you can join NCT06048094 on ClinicalTrials.gov

3. Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

   The spread of cancer to the brain is referred to as brain metastases. Brain metastases are a common complication of cancer. This study is being done to determine whether the use of a new imaging agent, 18F-fluciclovine, is able to detect which patients are responding to radiation therapy. In additi…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Miami Cancer Institute, Miami, Florida

   Run by

   Baptist Health South Florida

   See if you can join NCT04689048 on ClinicalTrials.gov

4. Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

   This study is for patients who have had surgery to remove brain metastasis and are planned to have stereotactic radiosurgery (SRS) after their brain surgery. It will be optional for patients to have a pre-surgery 18F-Fluciclovine PET/CT scan. The goal of the study is to determine whether a specific…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Miami Cancer Institute at Baptist Health South Florida, Miami, Florida

   Run by

   Baptist Health South Florida

   See if you can join NCT05554302 on ClinicalTrials.gov